| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $28K | $0-100.0% | $651K |
| Research and development | $6.0M-10.2% | $6.7M+21.1% | $5.5M |
| Selling, general and administrative | $7.5M-12.4% | $8.5M-28.8% | $12.0M |
| Total operating costs and expenses | $13.5M-11.4% | $15.3M-13.0% | $17.5M |
| Loss from operations | -$13.5M+11.6% | -$15.3M+9.7% | -$16.9M |
| Interest income and other income, net | $436K-35.8% | $679K-52.0% | $1.4M |
| Gain on sale of future payments | $0-100.0% | $1.2M | $0 |
| (Loss) gain on change in fair value of warrant liability | -$1.3M-283.4% | $717K-86.5% | $5.3M |
| Non-cash interest expense on liability related to the sale of future payments | $0+100.0% | -$394K | $0 |
| Total other income, net | -$879K-139.1% | $2.2M-65.9% | $6.6M |
| Net loss from continuing operations | -$14.4M-10.5% | -$13.0M-26.4% | -$10.3M |
| Net income from discontinued operations – See Note 3 | $73K | $0+100.0% | -$8.1M |
| Net loss | -$14.3M-9.9% | -$13.0M+29.3% | -$18.4M |
| Basic and diluted, continuing operations (in dollars per share) | -$0.34+32.0% | -$0.50+30.6% | -$0.72 |
| Basic and diluted, discontinued operations (in dollars per share) | $0.00 | $0.00+100.0% | -$0.57 |
| Basic and diluted loss per share (in dollars per share) | -$0.34+32.0% | -$0.50+61.2% | -$1.29 |
| Shares used in computing net loss per share of common stock, basic and diluted – See Note 10 (in shares) | $42410711.00+64.1% | $25845639.00+81.2% | $14263744.00 |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.